Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...

Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...

A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...

While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic ...

Moment of Clarity is pleased to offer TMS treatment. Moment of Clarity highlights Transcranial Magnetic Stimulation (TMS) as a safe, non-invasive treatment for depression, anxiety, and other mental ...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting more than 2.9 million people worldwide. It occurs when the ...

Former President Joe Biden is going through a new phase of treatment for prostate cancer, according to multiple media outlets ...